These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 32410650

  • 1. Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma.
    Chen P, Jiao L, Ren F, Wang DB.
    BMC Cancer; 2020 May 14; 20(1):423. PubMed ID: 32410650
    [Abstract] [Full Text] [Related]

  • 2. The predictive value of serum squamous cell carcinoma antigen in patients with cervical cancer who receive neoadjuvant chemotherapy followed by radical surgery: a single-institute study.
    Li X, Zhou J, Huang K, Tang F, Zhou H, Wang S, Jia Y, Sun H, Ma D, Li S.
    PLoS One; 2015 May 14; 10(4):e0122361. PubMed ID: 25860888
    [Abstract] [Full Text] [Related]

  • 3. [Clinical significance of serum squamous cell carcinoma antigen in patients with early cervical squamous cell carcinoma].
    Li D, Xu XX, Yan DD, Yuan SH, Lou HM.
    Zhonghua Zhong Liu Za Zhi; 2019 May 23; 41(5):357-362. PubMed ID: 31137169
    [Abstract] [Full Text] [Related]

  • 4. Predictive value of preoperative serum squamous cell carcinoma antigen (SCC-Ag) level on tumor recurrence in cervical squamous cell carcinoma patients treated with radical surgery: A single-institution study.
    Guo Q, Zhu J, Wu Y, Wen H, Xia L, Wu X, Ju X.
    Eur J Surg Oncol; 2020 Jan 23; 46(1):131-138. PubMed ID: 31481274
    [Abstract] [Full Text] [Related]

  • 5. Correlation Between Squamous Cell Carcinoma Antigen Level and the Clinicopathological Features of Early-Stage Cervical Squamous Cell Carcinoma and the Predictive Value of Squamous Cell Carcinoma Antigen Combined With Computed Tomography Scan for Lymph Node Metastasis.
    Xu D, Wang D, Wang S, Tian Y, Long Z, Ren X.
    Int J Gynecol Cancer; 2017 Nov 23; 27(9):1935-1942. PubMed ID: 28914639
    [Abstract] [Full Text] [Related]

  • 6. Preoperative serum SCC, CA125, and CA19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix.
    Takeda M, Sakuragi N, Okamoto K, Todo Y, Minobe S, Nomura E, Negishi H, Oikawa M, Yamamoto R, Fujimoto S.
    Acta Obstet Gynecol Scand; 2002 May 23; 81(5):451-7. PubMed ID: 12027820
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Assessment of retroperitoneal lymph node status in locally advanced cervical cancer.
    Li W, Xiong L, Zhu Q, Lu H, Zhong M, Liang M, Jiang W, Wang Y, Cheng W.
    BMC Cancer; 2021 May 01; 21(1):484. PubMed ID: 33933005
    [Abstract] [Full Text] [Related]

  • 11. Prognostic utility of squamous cell carcinoma antigen in carcinoma of the cervix: association with pre- and posttreatment FDG-PET.
    Olsen JR, Dehdashti F, Siegel BA, Zighelboim I, Grigsby PW, Schwarz JK.
    Int J Radiat Oncol Biol Phys; 2011 Nov 01; 81(3):772-7. PubMed ID: 20888130
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pretreatment Squamous Cell Carcinoma Antigen (SCC-Ag) as a Predictive Factor for the Use of Consolidation Chemotherapy in Cervical Cancer Patients After Postoperative Extended-Field Concurrent Chemoradiotherapy.
    Zhang G, Miao L, Wu H, Zhang Y, Fu C.
    Technol Cancer Res Treat; 2021 Nov 01; 20():15330338211044626. PubMed ID: 34605696
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix.
    Huang EY, Hsu HC, Sun LM, Chanchien CC, Lin H, Chen HC, Tseng CW, Ou YC, Chang HY, Fang FM, Huang YJ, Wang CY, Lu HM, Tsai CC, Ma YY, Fu HC, Wang YM, Wang CJ.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):1105-13. PubMed ID: 20932670
    [Abstract] [Full Text] [Related]

  • 17. Predictive value of preoperative serum squamous cell carcinoma antigen level for lymph node metastasis in early-stage cervical squamous cell carcinoma.
    Zhu C, Zhang W, Wang X, Jiao L, Chen L, Jiang J.
    Medicine (Baltimore); 2021 Aug 20; 100(33):e26960. PubMed ID: 34414964
    [Abstract] [Full Text] [Related]

  • 18. Pretreatment carcinoembryonic antigen level is a risk factor for para-aortic lymph node recurrence in addition to squamous cell carcinoma antigen following definitive concurrent chemoradiotherapy for squamous cell carcinoma of the uterine cervix.
    Huang EY, Huang YJ, Chanchien CC, Lin H, Wang CJ, Sun LM, Tseng CW, Tsai CC, Ou YC, Fu HC, Chen HC, Hsu HC, Wang CY.
    Radiat Oncol; 2012 Jan 30; 7():13. PubMed ID: 22289572
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervix.
    Bae SN, Namkoong SE, Jung JK, Kim CJ, Park JS, Kim JW, Lee JM, Kim SJ.
    Gynecol Oncol; 1997 Mar 30; 64(3):418-24. PubMed ID: 9062143
    [Abstract] [Full Text] [Related]

  • 20. [Correlation of serum squamous cell carcinoma antigen with clinico-pathological features and prognosis of squamous cell carcinoma of uterine cervix].
    Xiong Y, Liang LZ, Zheng M, Wei M, Shen Y.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jan 30; 42(1):29-33. PubMed ID: 17331418
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.